Fueled, in part, by the Capsugel acquisition, Lonza posted good gains in the first half and raised expectations for the full year. Organic sales increased 8.2% during the period to $3.2 billion. “The strong organic sales growth and margin improvements, particularly in our businesses along the healthcare continuum, helped us achieve a positive half-year 2018 result, which is why we are updating our outlook for the full year,” said Richard Ridinger, CEO of Lonza. “We look back at a successful f...